Status:
TERMINATED
Value of Tomosynthesis in Breast Lesion Characterization and Breast Cancer Staging
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Breast Cancer
Eligibility:
FEMALE
40+ years
Phase:
NA
Brief Summary
Study Rationale: an accurate breast cancer staging has a great impact in the management of a breast cancer. MRI is considered as the most sensible exam for this staging. However it has a low specifici...
Eligibility Criteria
Inclusion
- Women at least 40 years old
- Subject with a new lesion recommended for biopsy, whatever the modality which detected the lesion (clinical examination, mammography, tomosynthesis, US, or MRI)
Exclusion
- Subjects with BRCA mutation or at high genetic risk
- Subjects who have breast implants
- Personal history of breast cancer
- Subjects who are pregnant or who think they may be pregnant
- Subjects who are breast-feeding
- Subjects who are unable or unwilling to tolerate study constraints
- Subjects unable or unwilling to undergo informed consent
- Subject with no rights from the national health insurance programme
Key Trial Info
Start Date :
November 19 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
424 Patients enrolled
Trial Details
Trial ID
NCT01881880
Start Date
November 19 2012
End Date
December 1 2015
Last Update
May 29 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Private Hospital oh Antony
Antony, France, 92169
2
UH Grenoble
Grenoble, France, 34043
3
Oscar Lambret Center
Lille, France, 59000
4
Jean Mermoz Hospital
Lyon, France, 69008